Endothelium removal augments endothelium-independent vasodilatation in rat mesenteric vascular bed

Y. Iwatani, K. Kosugi, S. Isobe-Oku, S. Atagi, Yoshihisa Kitamura, H. Kawasaki

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background and purpose: The vascular endothelium regulates vascular tone by releasing various endothelium-derived vasoactive substances to counteract excess vascular response. We investigated whether the vascular endothelium regulates vasodilatation via released endothelium-derived contracting factors (EDCFs), by examining the effect of endothelium removal on responses to periarterial nerve stimulation (PNS) and various vasodilator agents. Experimental approach: The rat mesenteric vascular bed was perfused with Krebs solution. Vasodilator responses to PNS and 5 min perfusion of vasodilator agents in preparations with endothelium were compared with those in the same preparations without endothelium. The endothelium was removed by 30 s perfusion with sodium deoxycholate. Key results: Endothelium removal significantly augmented vasodilator responses to PNS and calcitonin gene-related peptide (CGRP), isoprenaline (β-adrenoceptor agonist), SNP and 8-bromo-cGMP (8-Br-cGMP; cGMP analogue) but not BAY41-2272 (soluble guanylate cyclase activator). The augmentation of SNP-induced vasodilatation after denudation was much greater than that of CGRP- or isoprenaline-induced vasodilatation. In the preparations with an intact endothelium, L-NAME (nitric oxide synthase inhibitor) significantly augmented vasodilator responses to PNS and CGRP, isoprenaline, SNP and 8-Br-cGMP, but not BAY41-2272. Indomethacin (cyclooxygenase inhibitor) and seratrodast (thromboxane A 2 receptor antagonist), but not phosphoramidon (endothelin-1-converting enzyme inhibitor) or BQ-123 (selective endothelin type A receptor antagonists), significantly augmented vasodilator responses to PNS and CGRP, isoprenaline, SNP and BAY41-2272. Conclusion and implication: These results suggest that the endothelium in rat mesenteric arteries regulates and maintains vascular tone via counteracting not only vasoconstriction through releasing endothelium-derived relaxing factors, but also vasodilatation, in part by releasing an EDCF, thromboxane A 2.

Original languageEnglish
Pages (from-to)32-40
Number of pages9
JournalBritish Journal of Pharmacology
Volume154
Issue number1
DOIs
Publication statusPublished - May 2008

Fingerprint

Vasodilation
Endothelium
Blood Vessels
Vasodilator Agents
Calcitonin Gene-Related Peptide
Isoproterenol
Single Nucleotide Polymorphism
seratrodast
Thromboxanes
Vascular Endothelium
varespladib methyl
Perfusion
Endothelium-Dependent Relaxing Factors
Mesenteric Arteries
Deoxycholic Acid
Cyclooxygenase Inhibitors
NG-Nitroarginine Methyl Ester
Enzyme Inhibitors
Endothelin-1
Vasoconstriction

Keywords

  • Calcitonin gene-related peptide
  • Endothelium-derived contracting factor
  • Endothelium-derived relaxing factor
  • Isoprenaline
  • Periarterial nerve stimulation
  • Sodium nitroprusside
  • Vascular endothelium removal
  • Vasodilatation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Endothelium removal augments endothelium-independent vasodilatation in rat mesenteric vascular bed. / Iwatani, Y.; Kosugi, K.; Isobe-Oku, S.; Atagi, S.; Kitamura, Yoshihisa; Kawasaki, H.

In: British Journal of Pharmacology, Vol. 154, No. 1, 05.2008, p. 32-40.

Research output: Contribution to journalArticle

Iwatani, Y. ; Kosugi, K. ; Isobe-Oku, S. ; Atagi, S. ; Kitamura, Yoshihisa ; Kawasaki, H. / Endothelium removal augments endothelium-independent vasodilatation in rat mesenteric vascular bed. In: British Journal of Pharmacology. 2008 ; Vol. 154, No. 1. pp. 32-40.
@article{f6f5e42bfaf247168f441e88ceedc20c,
title = "Endothelium removal augments endothelium-independent vasodilatation in rat mesenteric vascular bed",
abstract = "Background and purpose: The vascular endothelium regulates vascular tone by releasing various endothelium-derived vasoactive substances to counteract excess vascular response. We investigated whether the vascular endothelium regulates vasodilatation via released endothelium-derived contracting factors (EDCFs), by examining the effect of endothelium removal on responses to periarterial nerve stimulation (PNS) and various vasodilator agents. Experimental approach: The rat mesenteric vascular bed was perfused with Krebs solution. Vasodilator responses to PNS and 5 min perfusion of vasodilator agents in preparations with endothelium were compared with those in the same preparations without endothelium. The endothelium was removed by 30 s perfusion with sodium deoxycholate. Key results: Endothelium removal significantly augmented vasodilator responses to PNS and calcitonin gene-related peptide (CGRP), isoprenaline (β-adrenoceptor agonist), SNP and 8-bromo-cGMP (8-Br-cGMP; cGMP analogue) but not BAY41-2272 (soluble guanylate cyclase activator). The augmentation of SNP-induced vasodilatation after denudation was much greater than that of CGRP- or isoprenaline-induced vasodilatation. In the preparations with an intact endothelium, L-NAME (nitric oxide synthase inhibitor) significantly augmented vasodilator responses to PNS and CGRP, isoprenaline, SNP and 8-Br-cGMP, but not BAY41-2272. Indomethacin (cyclooxygenase inhibitor) and seratrodast (thromboxane A 2 receptor antagonist), but not phosphoramidon (endothelin-1-converting enzyme inhibitor) or BQ-123 (selective endothelin type A receptor antagonists), significantly augmented vasodilator responses to PNS and CGRP, isoprenaline, SNP and BAY41-2272. Conclusion and implication: These results suggest that the endothelium in rat mesenteric arteries regulates and maintains vascular tone via counteracting not only vasoconstriction through releasing endothelium-derived relaxing factors, but also vasodilatation, in part by releasing an EDCF, thromboxane A 2.",
keywords = "Calcitonin gene-related peptide, Endothelium-derived contracting factor, Endothelium-derived relaxing factor, Isoprenaline, Periarterial nerve stimulation, Sodium nitroprusside, Vascular endothelium removal, Vasodilatation",
author = "Y. Iwatani and K. Kosugi and S. Isobe-Oku and S. Atagi and Yoshihisa Kitamura and H. Kawasaki",
year = "2008",
month = "5",
doi = "10.1038/bjp.2008.72",
language = "English",
volume = "154",
pages = "32--40",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Endothelium removal augments endothelium-independent vasodilatation in rat mesenteric vascular bed

AU - Iwatani, Y.

AU - Kosugi, K.

AU - Isobe-Oku, S.

AU - Atagi, S.

AU - Kitamura, Yoshihisa

AU - Kawasaki, H.

PY - 2008/5

Y1 - 2008/5

N2 - Background and purpose: The vascular endothelium regulates vascular tone by releasing various endothelium-derived vasoactive substances to counteract excess vascular response. We investigated whether the vascular endothelium regulates vasodilatation via released endothelium-derived contracting factors (EDCFs), by examining the effect of endothelium removal on responses to periarterial nerve stimulation (PNS) and various vasodilator agents. Experimental approach: The rat mesenteric vascular bed was perfused with Krebs solution. Vasodilator responses to PNS and 5 min perfusion of vasodilator agents in preparations with endothelium were compared with those in the same preparations without endothelium. The endothelium was removed by 30 s perfusion with sodium deoxycholate. Key results: Endothelium removal significantly augmented vasodilator responses to PNS and calcitonin gene-related peptide (CGRP), isoprenaline (β-adrenoceptor agonist), SNP and 8-bromo-cGMP (8-Br-cGMP; cGMP analogue) but not BAY41-2272 (soluble guanylate cyclase activator). The augmentation of SNP-induced vasodilatation after denudation was much greater than that of CGRP- or isoprenaline-induced vasodilatation. In the preparations with an intact endothelium, L-NAME (nitric oxide synthase inhibitor) significantly augmented vasodilator responses to PNS and CGRP, isoprenaline, SNP and 8-Br-cGMP, but not BAY41-2272. Indomethacin (cyclooxygenase inhibitor) and seratrodast (thromboxane A 2 receptor antagonist), but not phosphoramidon (endothelin-1-converting enzyme inhibitor) or BQ-123 (selective endothelin type A receptor antagonists), significantly augmented vasodilator responses to PNS and CGRP, isoprenaline, SNP and BAY41-2272. Conclusion and implication: These results suggest that the endothelium in rat mesenteric arteries regulates and maintains vascular tone via counteracting not only vasoconstriction through releasing endothelium-derived relaxing factors, but also vasodilatation, in part by releasing an EDCF, thromboxane A 2.

AB - Background and purpose: The vascular endothelium regulates vascular tone by releasing various endothelium-derived vasoactive substances to counteract excess vascular response. We investigated whether the vascular endothelium regulates vasodilatation via released endothelium-derived contracting factors (EDCFs), by examining the effect of endothelium removal on responses to periarterial nerve stimulation (PNS) and various vasodilator agents. Experimental approach: The rat mesenteric vascular bed was perfused with Krebs solution. Vasodilator responses to PNS and 5 min perfusion of vasodilator agents in preparations with endothelium were compared with those in the same preparations without endothelium. The endothelium was removed by 30 s perfusion with sodium deoxycholate. Key results: Endothelium removal significantly augmented vasodilator responses to PNS and calcitonin gene-related peptide (CGRP), isoprenaline (β-adrenoceptor agonist), SNP and 8-bromo-cGMP (8-Br-cGMP; cGMP analogue) but not BAY41-2272 (soluble guanylate cyclase activator). The augmentation of SNP-induced vasodilatation after denudation was much greater than that of CGRP- or isoprenaline-induced vasodilatation. In the preparations with an intact endothelium, L-NAME (nitric oxide synthase inhibitor) significantly augmented vasodilator responses to PNS and CGRP, isoprenaline, SNP and 8-Br-cGMP, but not BAY41-2272. Indomethacin (cyclooxygenase inhibitor) and seratrodast (thromboxane A 2 receptor antagonist), but not phosphoramidon (endothelin-1-converting enzyme inhibitor) or BQ-123 (selective endothelin type A receptor antagonists), significantly augmented vasodilator responses to PNS and CGRP, isoprenaline, SNP and BAY41-2272. Conclusion and implication: These results suggest that the endothelium in rat mesenteric arteries regulates and maintains vascular tone via counteracting not only vasoconstriction through releasing endothelium-derived relaxing factors, but also vasodilatation, in part by releasing an EDCF, thromboxane A 2.

KW - Calcitonin gene-related peptide

KW - Endothelium-derived contracting factor

KW - Endothelium-derived relaxing factor

KW - Isoprenaline

KW - Periarterial nerve stimulation

KW - Sodium nitroprusside

KW - Vascular endothelium removal

KW - Vasodilatation

UR - http://www.scopus.com/inward/record.url?scp=42949142058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949142058&partnerID=8YFLogxK

U2 - 10.1038/bjp.2008.72

DO - 10.1038/bjp.2008.72

M3 - Article

C2 - 18332859

AN - SCOPUS:42949142058

VL - 154

SP - 32

EP - 40

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 1

ER -